For the Quarter Ending March 2026
Aciclovir Prices in North America
- In United States, the Aciclovir Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- During March 2026, retail sales grew 4.0% year-over-year and CPI rose 3.3%, supporting the Aciclovir Demand Outlook.
- In March 2026, PPI increased 4.0% year-over-year and industrial production rose 0.7%, elevating the Aciclovir Production Cost Trend.
- During March 2026, unemployment reached 4.3% and consumer confidence hit 91.8, maintaining insured patient Aciclovir demand.
- The Manufacturing Index expanded in March 2026, indicating robust industrial activity for Aciclovir active pharmaceutical ingredients.
- Methanol feedstock costs and Brent crude oil surged in March 2026, increasing upstream Aciclovir synthesis expenses.
- Conversely, acetic acid and dimethylformamide precursor costs plummeted or stabilized during January-March 2026, partially offsetting expenses.
- Aciclovir import volumes fluctuated and inventory cycles lengthened in Q1 2026 due to new tariff implementations.
- The Aciclovir Price Forecast indicated upward pressure throughout Q1 2026 as suppliers navigated shifting regulatory frameworks.
Why did the price of Aciclovir change in March 2026 in North America?
- Aciclovir production costs spiked in March 2026 due to surging upstream methanol and energy inflation.
- Tariff implementations in January 2026 reshaped supply chains, increasing Aciclovir active pharmaceutical ingredient import expenses.
- Strong retail sales in March 2026 sustained robust consumer demand for Aciclovir despite rising prices.
Aciclovir Prices in Europe
- In Germany, the Aciclovir Price Index rose quarter-over-quarter in Q1 2026, driven by severe domestic supply shortages.
- Consumer inflation reached 2.7% in March 2026, while producer prices declined by 0.2% during the same period.
- The Manufacturing Index expanded in March 2026, despite stagnant industrial production recorded at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment remained stable at 4.2% in February 2026, supporting Aciclovir Demand Outlook.
- Consumer confidence fell to -24.7 in March 2026, negatively impacting premium over-the-counter Aciclovir demand across the region.
- The Aciclovir Production Cost Trend increased in March 2026 as naphtha, methanol, and ethylene precursor prices surged.
- Active pharmaceutical ingredient imports became severely constrained in Q1 2026, causing domestic Aciclovir stockpiles to dwindle rapidly.
- The Aciclovir Price Forecast indicated upward pressure in March 2026 due to elevated demand for off-patent medicines.
Why did the price of Aciclovir change in March 2026 in Europe?
- Naphtha and methanol feedstock costs surged significantly in March 2026, driving up Aciclovir production expenses.
- Essential medicine availability deteriorated in March 2026, exacerbating domestic supply shortages for off-patent antiviral treatments.
- Shipping disruptions severely constrained active pharmaceutical ingredient imports from Asia into Europe during March 2026.
Aciclovir Prices in APAC
- In China, the Aciclovir Price Index rose quarter-over-quarter in Q1 2026, driven by rising raw material costs.
- The Aciclovir Production Cost Trend increased in March 2026 as national producer prices rose 0.5% year-over-year.
- Consumer inflation rose 1.0% while retail sales grew 1.7% in March 2026, impacting retail Aciclovir sales.
- The Aciclovir Demand Outlook softened in March 2026 because the urban unemployment rate reached exactly 5.4%.
- Consumer confidence remained low at 86.0 in Q1 2026, while domestic Aciclovir API inventories tightened significantly.
- Industrial production grew 5.7% in March 2026, ensuring ample domestic supply capabilities for bulk Aciclovir APIs.
- The Manufacturing Index expanded in March 2026, aligning with surged pharmaceutical API export volumes in February 2026.
- The Aciclovir Price Forecast reflected upward momentum in Q1 2026 as domestic guanine feedstock demand surged.
Why did the price of Aciclovir change in March 2026 in APAC?
- Producer prices rose 0.5% in March 2026, directly increasing Aciclovir active pharmaceutical ingredient production costs.
- Demand for essential guanine and guanosine feedstocks surged significantly during the Q1 2026 reporting period.
- Domestic small-molecule API inventories tightened in Q1 2026 while pharmaceutical exports surged in February 2026.
For the Quarter Ending December 2025
Aciclovir Prices in North America
- In United States, the Aciclovir Price Index rose in Q4 2025, driven by rising production costs and tightening regional supply.
- Aciclovir production costs increased from a 2.7% CPI rise year-over-year in December 2025, affecting raw materials and labor.
- Input costs for Aciclovir manufacturing rose, with PPI increasing 3.0% year-over-year in November 2025.
- North American ammonia feedstock costs trended upward in October 2025, impacting Aciclovir production expenses.
- Natural gas prices, a key energy input for Aciclovir, surged in December 2025 due to a cold snap.
- Aciclovir demand was supported by a 3.3% retail sales increase and 89.1 consumer confidence in December 2025.
- A 4.4% unemployment rate in December 2025 indicated a strong labor market, bullish for Aciclovir demand.
- Industrial production increased 2.0% year-over-year in December 2025, supporting Aciclovir supply stability.
- The Aciclovir Price Forecast suggests continued upward pressure from persistent cost increases and supply constraints.
Why did the price of Aciclovir change in December 2025 in North America?
- Natural gas prices, a key energy input, surged in December 2025 from a cold snap.
- US methanol feedstock costs declined in December 2025 from year-end inventory liquidation.
- CPI increased 2.7% year-over-year in December 2025, raising Aciclovir production expenses.
Aciclovir Prices in APAC
- In China, the Aciclovir Price Index remained stable in Q4 2025, influenced by subdued consumer inflation of 0.8% in December 2025.
- Aciclovir production costs declined in December 2025, as the producer price index fell by 1.9% year-over-year.
- Aciclovir demand outlook was tempered in Q4 2025, with retail sales growing only 0.9% year-over-year in December 2025.
- The Manufacturing Index expanded in December 2025, supporting stable supply chains for Aciclovir production.
- Industrial production grew by 5.2% year-over-year in December 2025, indicating robust manufacturing activity.
- High guanine raw material costs continued to constrain Aciclovir production capacity during Q4 2025.
- China's pharmaceutical market maintained healthy growth in Q4 2025, driven by post-pandemic recovery.
- Healthcare financing activity strongly recovered in Q4 2025, positively impacting the Aciclovir market.
- Aciclovir prices were assessed at USD 54840 / MT in Q4.
Why did the price of Aciclovir change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, reducing Aciclovir manufacturing input costs.
- Subdued consumer price index at 0.8% year-over-year in December 2025 indicated weak demand-side inflation.
- High guanine raw material costs continued to constrain production capacity for Aciclovir in Q4 2025.
Aciclovir Prices in Europe
- In Germany, the Aciclovir Price Index remained stable or slightly declined in Q4 2025, influenced by lower industrial input costs in December 2025.
- Aciclovir production costs faced upward pressure from high energy and raw material costs throughout Q4 2025.
- The Producer Price Index declined -2.5% year-on-year in December 2025, indicating reduced industrial input costs.
- Aciclovir demand was supported by moderate pharmaceutical market growth and substantial prescription volumes in Q4 2025.
- Retail sales grew 1.1% year-on-year in November 2025, supporting over-the-counter Aciclovir demand.
- Consumer confidence declined to -17.5 in December 2025, and a 6.2% unemployment rate dampened demand.
- Moderate inflation, with CPI at 1.8% year-on-year in December 2025, increased Aciclovir operational costs.
- German chemical production declined in Q4 2025, with capacity utilization at a low 70% during 2025.
- Industrial production grew 0.8% year-on-year in October 2025, indicating stable, slow economic activity.
- Why did the price of Aciclovir change in December 2025 in Europe?
- Production costs were influenced by persistently high energy and raw material costs in Q4 2025.
- A -2.5% Producer Price Index year-on-year in December 2025 indicated lower industrial input costs.
- Demand for generics like Aciclovir was supported by moderate pharmaceutical market growth in Q4 2025.
For the Quarter Ending September 2025
Aciclovir Prices in North America
- In the United States, the Aciclovir Price Index rose quarter-over-quarter in Q3 2025, influenced by rising producer costs.
- Aciclovir production costs faced upward pressure from a 2.6% PPI increase in August 2025 and 3.0% CPI in September 2025.
- Demand for Aciclovir was supported by a 5.42% retail sales increase and low 4.3% unemployment in September 2025.
- The Aciclovir Price Forecast suggests continued upward pressure due to persistent inflation and robust consumer spending.
- Overall pharmaceutical market demand is anticipated to rise in 2025, driving the Aciclovir Demand Outlook.
- Wholesale inventories declined slightly in August 2025, while industrial production increased 0.1% in September 2025.
- US natural gas prices stabilized and moderated during Q3 2025, easing some Aciclovir production cost pressures.
- Consumer confidence declined to 94.2 in September 2025, potentially tempering demand for OTC Aciclovir products.
Why did the price of Aciclovir change in September 2025 in North America?
- Rising PPI (2.6% in August 2025) increased Aciclovir manufacturing costs.
- Strong retail sales, up 5.42% in September 2025, supported Aciclovir demand and pricing power.
- Consumer confidence declined to 94.2 in September 2025, potentially limiting demand for discretionary Aciclovir purchases.
Aciclovir Price in APAC
- In China, the Aciclovir Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
- Aciclovir production costs faced downward pressure as the Producer Price Index declined 2.3% year-on-year in September 2025.
- Demand outlook for Aciclovir was challenged by a 0.3% year-on-year decrease in the Consumer Price Index in September 2025.
- The Manufacturing Index was contracting in September 2025, suggesting a slowdown in overall industrial activity.
- Aciclovir demand faced headwinds from a 5.2% unemployment rate and low consumer confidence (89.6 index) in September 2025.
- Industrial production expanded 6.5% year-on-year in September 2025, supporting a stable environment for Aciclovir supply.
- General chemical overcapacity persisted in China during Q3 2025, contributing to stable production costs for Aciclovir.
- Retail sales increased 3.0% year-on-year in September 2025, indicating healthy consumer spending despite other economic pressures.
- China's chemical production capacity continued to expand in Q3 2025, maintaining higher operating rates for self-sufficiency.
- Petrochemical feedstock prices, including benzene, remained relatively stable in early Q3 2025, impacting Aciclovir input costs.
Why did the price of Aciclovir change in September 2025 in APAC?
- Producer Price Index declined 2.3% year-on-year in September 2025, reducing Aciclovir manufacturing costs.
- Consumer Price Index decreased 0.3% year-on-year in September 2025, indicating broader deflationary pressures.
- Manufacturing Index was contracting in September 2025, signaling a slowdown in industrial activity and demand.
Aciclovir Price in Europe
- In Germany, the Aciclovir Price Index remained stable in Q3 2025, influenced by rising consumer inflation and declining producer prices.
- Aciclovir production costs trended lower in September 2025 due to a 1.7% year-over-year decline in producer prices.
- Demand for Aciclovir saw moderate growth in Q3 2025, supported by Germany's aging population and chronic disease prevalence.
- A contracting Manufacturing Index in Q3 2025 and 1.0% industrial production decline impacted Aciclovir supply chain.
- Elevated wholesale electricity prices in Q3 2025, driven by higher natural gas costs, sustained Aciclovir manufacturing expenses.
- Retail sales increased 0.2% in September 2025, mildly supporting over-the-counter Aciclovir demand.
- Stable unemployment at 6.3% in September 2025 suggests potential affordability barriers for Aciclovir consumers.
- Weakening international business and US tariffs in July 2025 negatively impacted German chemical and pharmaceutical trade.
Why did the price of Aciclovir change in September 2025 in Europe?
- Lower producer prices, down 1.7% year-over-year in September 2025, reduced Aciclovir manufacturing costs.
- Elevated wholesale electricity prices in Q3 2025, from natural gas costs, sustained Aciclovir operational expenses.
- Contracting Manufacturing Index in Q3 2025 and declining industrial production impacted Aciclovir supply chain.
